CRSP

Latest SEC Filings & News for CRSP

2 most recent filings and news items mentioning CRSP. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/CRSP/news?limit=20"

Pull CRSP filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

EarningsAug 3, 2026Positive

CRISPR Q2 Revenue Rose 151% YoY As FDA Approved CASGEVY for Children Aged 2+

CRISPR Therapeutics reported strong second-quarter financial results with CASGEVY revenue rising 151% year-over-year. The FDA recently expanded CASGEVY approval to children as young as 2 years old, while the company initiated new Phase 1 trials for in vivo candidates CTX340 and C

View filing at SEC.gov →

RegulatoryJun 4, 2026Neutral

CRISPR Therapeutics files updated articles of association

CRISPR Therapeutics AG filed amended articles of association as Exhibit 3.1 to an 8-K filing, updating corporate governance documents. The filing is administrative in nature with no material operational or financial impact disclosed.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.